Insider Buying is Anemic- BUT WE STILL FIND SOMETHING TO BUY $APD,$CCI,$URI

Insider Buying is Anemic- Insider Buying is Anemic- BUT WE STILL FIND SOMETHING TO BUY $APD,$CCI,$URI -try these names on for size Week Ending 7-26-19 Two large-cap buyers have excellent track records. Air Products and Chemicals (APD) CEO Ghasemi is batting 8 out of 9 on winning trades showing exemplary timing.  It’s also very bullish when the CEO buys the stock at the top of the price range as was his $4.54 M buy at $227.16 Another interesting buy was Chairman Martin Landis purchase of cell phone tower REIT Crown Castle International (CCI) $2,07 M at $127.33.  It’s hard to … Read more

Eyenovia merits a closer look $EVEN

CEO Ianchulev purchase of microcap Eyenovia merits a closer look. This was part of a spot 4.38 M share spot secondary at $2.78. Eyenovia is marketing a high tech eyedropper.  The 100-year-old eyedropper could be disrupted by Eyenovia. Buyer beware though, it’s easy to get in but not so easy to get out of this low volume late-stage money-losing biotech. Health Equity insiders score big by scooping up 10,000 shares each on secondary. Unfortunately, there was no way to act on this until the 15th SEC filing after the stock had risen 10 points. Insiders are required to file within … Read more